Pharmaceutical companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 44 pharmaceutical companies in the United States ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 20 Nov 2026, 11:35 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Erasca+395%
- Median
- +27.7%
- Combined market value
- ZAR 65.2T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | ZAR 87.1B | ZAR 248.16 | 3.34% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | ZAR 161.8B | ZAR 1,703.76 | 3.77% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | ZAR 115.5B | ZAR 1,702.71 | 1.91% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | ZAR 91.6B | ZAR 2,170.75 | 0.38% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | ZAR 70.4B | ZAR 514.46 | 1.24% up | 168% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | +108% | ZAR 83.4B | ZAR 1,480.39 | 1.01% up | 108% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +103% | ZAR 171.1B | ZAR 1,132.23 | 1.88% down | 103% up | ||
| 8 | ViatrisVTRS · Health Care | +99.0% | ZAR 397.7B | ZAR 346.93 | 1.97% down | 99% up | ||
| 9 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | ZAR 130.1B | ZAR 373.28 | 2.24% down | 90% up | ||
| 10 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | ZAR 151.7B | ZAR 5,425.58 | 1.87% up | 86% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | ZAR 78.7B | ZAR 718.47 | 0.48% down | 86% up | ||
| 12 | Royalty PharmaRPRX · Health Care | +78.9% | ZAR 679.5B | ZAR 1,181.80 | 1.38% down | 79% up | ||
| 13 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | ZAR 141.3B | ZAR 2,164.30 | 2.47% down | 51% up | ||
| 14 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | ZAR 100.2B | ZAR 5,007.45 | 3.94% down | 50% up | ||
| 15 | Merck & CoMRK · Health Care | +45.1% | ZAR 5.71T | ZAR 2,317.69 | 3.61% down | 45% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | +44.7% | ZAR 80.9B | ZAR 842.89 | 3.86% down | 45% up | ||
| 17 | Belite BioBLTE · Health Care | +43.1% | ZAR 107B | ZAR 2,635.48 | 3.33% down | 43% up | ||
| 18 | Johnson & JohnsonJNJ · Health Care | +34.3% | ZAR 11.22T | ZAR 4,661.91 | 2.04% down | 34% up | ||
| 19 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | ZAR 108.8B | ZAR 1,666.76 | 3.27% up | 34% up | ||
| 20 | Eli LillyLLY · Health Care | +32.5% | ZAR 21T | ZAR 23,578.67 | 2.29% down | 33% up | ||
| 21 | Bristol-Myers SquibbBMY · Health Care | +29.6% | ZAR 2.08T | ZAR 1,018.10 | 2.05% down | 30% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | ZAR 1.67T | ZAR 16,113.39 | 2.35% down | 28% up | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | ZAR 2.3T | ZAR 9,086.14 | 2.94% down | 27% up | ||
| 24 | Elanco Animal HealthELAN · Health Care | +25.7% | ZAR 229.3B | ZAR 458.79 | 1.54% down | 26% up | ||
| 25 | AbbVieABBV · Health Care | +24.7% | ZAR 8.75T | ZAR 4,948.11 | 0.86% down | 25% up | ||
| 26 | United TherapeuticsUTHR · Health Care | +21.6% | ZAR 415.5B | ZAR 9,756.97 | 3.16% down | 22% up | ||
| 27 | BridgeBio PharmaBBIO · Health Care | +20.7% | ZAR 265.8B | ZAR 1,364.33 | 0.22% up | 21% up | ||
| 28 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | ZAR 141.3B | ZAR 2,038.30 | 1.88% down | 18% up | ||
| 29 | PfizerPFE · Health Care | +15.0% | ZAR 2.74T | ZAR 480.61 | 1.85% down | 15% up | ||
| 30 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | ZAR 107.7B | ZAR 761.74 | 1.25% up | 13% up | ||
| 31 | BioMarin PharmaceuticalBMRN · Health Care | +12.3% | ZAR 207.6B | ZAR 1,071.85 | 0.02% down | 12% up | ||
| 32 | Axsome TherapeuticsAXSM · Health Care | -6.50% | ZAR 124.5B | ZAR 2,367.78 | 1.25% up | 6% down | ||
| 33 | Corcept TherapeuticsCORT · Health Care | -9.67% | ZAR 124.1B | ZAR 1,133.98 | 4.15% down | 10% down | ||
| 34 | Abbott LaboratoriesABT · Health Care | -15.7% | ZAR 3.14T | ZAR 1,812.66 | 0.58% down | 16% down | ||
| 35 | CytokineticsCYTK · Health Care | -19.2% | ZAR 125.1B | ZAR 898.04 | 0.27% up | 19% down | ||
| 36 | Cogent BiosciencesCOGT · Health Care | -19.9% | ZAR 84.2B | ZAR 484.10 | 0.25% down | 20% down | ||
| 37 | PTC TherapeuticsPTCT · Health Care | -21.2% | ZAR 85B | ZAR 1,017.84 | 3.16% down | 21% down | ||
| 38 | ZoetisZTS · Health Care | -26.2% | ZAR 572.9B | ZAR 1,409.88 | 5.59% down | 26% down | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | ZAR 160.8B | ZAR 6,923.59 | 0.34% down | 27% down | ||
| 40 | Summit TherapeuticsSMMT · Health Care | -34.7% | ZAR 147.5B | ZAR 184.46 | 0.67% up | 35% down | ||
| 41 | InsmedINSM · Health Care | -40.0% | ZAR 553.1B | ZAR 2,521.00 | 20.58% up | 40% down | ||
| 42 | Legend BiotechLEGN · Health Care | -41.0% | ZAR 54.5B | ZAR 280.96 | 0.92% down | 41% down | ||
| 43 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | ZAR 79.1B | ZAR 475.02 | 0.62% down | 63% down | ||
| 44 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | ZAR 345.5B | ZAR 2,579.64 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4512 ZAR).
Questions and answers
Which pharmaceutical companies in the United States rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 44 pharmaceutical companies in the United States ranked by one-year price change as of 20 Nov 2026, 11:35 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by one-year price change.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by one-year price change have a combined market value of ZAR 65.2T as of 20 Nov 2026, 11:35 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by one-year price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.